Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program

Abstract Epithelial‐to‐mesenchymal transition (EMT) is a recognized eukaryotic cell differentiation program that is also observed in association with invasive tumors. Partial EMT program in carcinomas imparts cancer cells with mesenchymal‐like features and is proposed as essential for metastasis. Pr...

Full description

Bibliographic Details
Main Authors: Yang Chen, Valerie S LeBleu, Julienne L Carstens, Hikaru Sugimoto, Xiaofeng Zheng, Shruti Malasi, Dieter Saur, Raghu Kalluri
Format: Article
Language:English
Published: Springer Nature 2018-10-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201809085
_version_ 1797283866444038144
author Yang Chen
Valerie S LeBleu
Julienne L Carstens
Hikaru Sugimoto
Xiaofeng Zheng
Shruti Malasi
Dieter Saur
Raghu Kalluri
author_facet Yang Chen
Valerie S LeBleu
Julienne L Carstens
Hikaru Sugimoto
Xiaofeng Zheng
Shruti Malasi
Dieter Saur
Raghu Kalluri
author_sort Yang Chen
collection DOAJ
description Abstract Epithelial‐to‐mesenchymal transition (EMT) is a recognized eukaryotic cell differentiation program that is also observed in association with invasive tumors. Partial EMT program in carcinomas imparts cancer cells with mesenchymal‐like features and is proposed as essential for metastasis. Precise determination of the frequency of partial EMT program in cancer cells in tumors and its functional role in metastases needs unraveling. Here, we employed mesenchymal cell reporter mice driven by αSMA‐Cre and Fsp1‐Cre with genetically engineered mice that develop spontaneous pancreatic ductal adenocarcinoma (PDAC) to monitor partial EMT program. Both αSMA‐ and Fsp1‐Cre‐mediated partial EMT programs were observed in the primary tumors. The established metastases were primarily composed of cancer cells without evidence for a partial EMT program, as assessed by our fate mapping approach. In contrast, metastatic cancer cells exhibiting a partial EMT program were restricted to isolated single cancer cells or micrometastases (3–5 cancer cells). Collectively, our studies identify large metastatic nodules with preserved epithelial phenotype and potentially unravel a novel metastasis program in PDAC.
first_indexed 2024-03-07T17:37:03Z
format Article
id doaj.art-7240628df48e479797a97ac8d277c95a
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2024-03-07T17:37:03Z
publishDate 2018-10-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-7240628df48e479797a97ac8d277c95a2024-03-02T16:35:04ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842018-10-011010n/an/a10.15252/emmm.201809085Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis programYang Chen0Valerie S LeBleu1Julienne L Carstens2Hikaru Sugimoto3Xiaofeng Zheng4Shruti Malasi5Dieter Saur6Raghu Kalluri7Department of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USADepartment of Medicine II Klinikum rechts der Isar Technische Universität München München GermanyDepartment of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston TX USAAbstract Epithelial‐to‐mesenchymal transition (EMT) is a recognized eukaryotic cell differentiation program that is also observed in association with invasive tumors. Partial EMT program in carcinomas imparts cancer cells with mesenchymal‐like features and is proposed as essential for metastasis. Precise determination of the frequency of partial EMT program in cancer cells in tumors and its functional role in metastases needs unraveling. Here, we employed mesenchymal cell reporter mice driven by αSMA‐Cre and Fsp1‐Cre with genetically engineered mice that develop spontaneous pancreatic ductal adenocarcinoma (PDAC) to monitor partial EMT program. Both αSMA‐ and Fsp1‐Cre‐mediated partial EMT programs were observed in the primary tumors. The established metastases were primarily composed of cancer cells without evidence for a partial EMT program, as assessed by our fate mapping approach. In contrast, metastatic cancer cells exhibiting a partial EMT program were restricted to isolated single cancer cells or micrometastases (3–5 cancer cells). Collectively, our studies identify large metastatic nodules with preserved epithelial phenotype and potentially unravel a novel metastasis program in PDAC.https://doi.org/10.15252/emmm.201809085dual‐recombinase systemmetastasismicrometastasispancreatic ductal adenocarcinomapartial epithelial‐to‐mesenchymal transition
spellingShingle Yang Chen
Valerie S LeBleu
Julienne L Carstens
Hikaru Sugimoto
Xiaofeng Zheng
Shruti Malasi
Dieter Saur
Raghu Kalluri
Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
EMBO Molecular Medicine
dual‐recombinase system
metastasis
micrometastasis
pancreatic ductal adenocarcinoma
partial epithelial‐to‐mesenchymal transition
title Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
title_full Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
title_fullStr Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
title_full_unstemmed Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
title_short Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
title_sort dual reporter genetic mouse models of pancreatic cancer identify an epithelial to mesenchymal transition independent metastasis program
topic dual‐recombinase system
metastasis
micrometastasis
pancreatic ductal adenocarcinoma
partial epithelial‐to‐mesenchymal transition
url https://doi.org/10.15252/emmm.201809085
work_keys_str_mv AT yangchen dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT valerieslebleu dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT juliennelcarstens dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT hikarusugimoto dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT xiaofengzheng dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT shrutimalasi dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT dietersaur dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram
AT raghukalluri dualreportergeneticmousemodelsofpancreaticcanceridentifyanepithelialtomesenchymaltransitionindependentmetastasisprogram